SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-019496
Filing Date
2024-01-30
Accepted
2024-01-30 16:54:53
Documents
17
Period of Report
2024-01-29
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d761446d8k.htm   iXBRL 8-K 31742
2 EX-1.1 d761446dex11.htm EX-1.1 201482
3 EX-5.1 d761446dex51.htm EX-5.1 9136
7 GRAPHIC g761446g32u83.jpg GRAPHIC 2793
  Complete submission text file 0001193125-24-019496.txt   433131

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA vera-20240129.xsd EX-101.SCH 2835
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE vera-20240129_lab.xml EX-101.LAB 18737
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vera-20240129_pre.xml EX-101.PRE 11697
18 EXTRACTED XBRL INSTANCE DOCUMENT d761446d8k_htm.xml XML 3783
Mailing Address 8000 MARINA BOULEVARD, SUITE 120 BRISBANE CA 94005
Business Address 8000 MARINA BOULEVARD, SUITE 120 BRISBANE CA 94005 650-770-0077
Vera Therapeutics, Inc. (Filer) CIK: 0001831828 (see all company filings)

IRS No.: 812744449 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40407 | Film No.: 24578932
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)